The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
November 20th 2024
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
High-quality ultrasound demonstrates measureable effect in ovarian cancer management
February 4th 2008Ultrasound exams conducted by expert sonographers make a measurable difference over routine exams in the treatment of suspected ovarian cancer, decreasing the number of major staging procedures and reducing in-patient hospital stays.
Breast ultrasound adjusts to get past false positives
January 10th 2008The massive American College of Radiology Imaging Network 6666 trial shows that adding ultrasound to the initial breast screening protocol for high-risk women could help detect 30% more cancers, but at the questionable cost of many more needless biopsies of benign lesions.
Lack of national diagnosis, care plan spurs call for action
January 10th 2008Prostate cancer imaging experts sent out a clear message in 2007: Prostate cancer in the U.S. has become an unrecognized patient care crisis that needs tackling. The good news is these experts agree that advanced imaging technologies could help in early detection and minimally invasive treatment. The lack of a cohesive national strategy is worrisome, however, and they want to see the adoption of a broad initiative for diagnosing and treating prostate cancer similar to that for breast cancer.
MR elastography proves edge in liver fibrosis staging
January 10th 2008Researchers in Belgium have found that MR elastography is more accurate than a blood test commonly used in the noninvasive staging of liver fibrosis. The study adds weight to clinical literature that suggests MR elastography could replace biopsy.
FDA warning flummoxes ultrasound contrast trial
January 10th 2008Plans for a clinical trial designed to overcome long-standing regulatory obstacles to the general clinical use of ultrasound contrast media in the U.S. have been knocked off track by an FDA-mandated black box safety warning for two microbubble agents approved for echocardiography.
Fractures and liver lesions top list of residents' ER misses
January 10th 2008Researchers used a customized search engine to quickly find that most discordant resident versus attending physician preliminary reports involved fractures, liver/kidney lesions, pulmonary nodules, and gastrointestinal wall thickening.
Breast MR imaging aids high-risk women
January 10th 2008A large prospective screening trial from the University of Pennsylvania compared screen-film mammography, digital mammography, whole-breast ultrasound, and contrast-enhanced MRI in a population of 569 asymptomatic women. In this single-center trial, funded by the National Cancer Institute, the definition of high risk included women with a 25% lifetime risk based on genetic testing or Gail or Claus models and those with a history of cancer in the contralateral breast.
‘Care areas’ characterize GE approach to ultrasound
January 3rd 2008GE Healthcare this week introduced two tailored, highly portable ultrasound systems, one for emergency medicine, the other for anesthesia. Although these systems are narrowly focused in the clinical sense, they reflect a multifaceted corporate approach to ultrasound that leverages different technologies to achieve specific goals.
New GE units address rising demand for hand-carried ultrasound
January 3rd 2008The worldwide market for compact ultrasound scanners is expected to grow 36% in 2007, according to Harvey Klein, ultrasound industry analyst and president of Klein Biomedical Consultants. GE reports that global revenue from the sale of compact ultrasound systems grew to $175 million in the third quarter, a 65% gain over the year-earlier period.